Underground Biohacking

CJC-1295 dosing calculator

CompoundCJC-1295
mg
mL

1 mg = 1000 mcg.

Your syringe
Draw this much

Enter a vial size, water volume and dose to see where to pull.

51015202530102030
0 units0.3 mL barrel, U-100 scale30 units

For tracking and calculation purposes only. Not medical advice. Based on a standard U-100 insulin syringe.

This calculator has no pre-filled dose for CJC-1295. We pre-fill a dose only from an approved label or a human trial arm that fits this tool, and none does.

How the units are worked out

Your vial holds a fixed amount of peptide. The water you add sets the concentration (how much peptide sits in each millilitre). The concentration then decides how much liquid carries your dose.

Three steps, in order:

  1. Concentration (mcg/mL) = peptide in the vial (mcg) divided by water added (mL).
  2. Volume (mL) = your dose (mcg) divided by the concentration (mcg/mL).
  3. Units to draw = volume (mL) multiplied by 100.

That last step is the syringe, not the peptide. A U-100 insulin syringe is marked so 100 units hold 1 mL, so 0.1 mL reads as 10 units.

A worked example

Enter your dose in the calculator above and this line shows the numbers worked through.

Water and units at a glance

CJC-1295 at different mixes. Every row opens the calculator on that mix.

VialWaterConcentration
5 mg1 mL5,000 mcg/mL
5 mg2 mL2,500 mcg/mL
5 mg3 mL1,667 mcg/mL
5 mg5 mL1,000 mcg/mL
10 mg1 mL10,000 mcg/mL
10 mg2 mL5,000 mcg/mL
10 mg3 mL3,333 mcg/mL
10 mg5 mL2,000 mcg/mL

Units appear once you enter a dose.

The pre-filled vial size is the most-used size in WPA dosing data (Aug 2026), or our vendors' most common size where WPA data is thin. The water is the most-used amount in WPA data. There is no pre-filled dose. Not a recommendation.

Mixing and storage

Run the water down the inside wall of the vial and let the powder dissolve on its own. Never shake it. Label the vial with the compound, the total mass, the water you added, the concentration and the date. A sealed freeze-dried vial keeps 12 to 24 months in the fridge at 2 to 8°C. Once mixed with preserved water, such as bacteriostatic water, that drops to roughly 28 days refrigerated. Keep it at the back of the fridge, away from light and away from the door's temperature swings.

Other compounds

Questions

What is the difference between CJC-1295 with DAC and without DAC?
They are different drugs sharing one name. CJC-1295 with DAC carries a chemical hook that binds albumin in your blood. That keeps it signalling for days, and it is the form used in the published human trials. CJC-1295 without DAC has no hook. It is modified GRF 1-29, and it clears from the blood fast. No human trial has been published on the version without DAC, so its effects in people are unmeasured.
Does CJC-1295 actually build muscle or burn fat?
Nobody has measured that in people. The human trials tracked blood levels of growth hormone and IGF-1, and nothing else. They did not weigh anyone, scan body fat or test strength. Higher IGF-1 is a plausible route to those changes, but plausible is not proven. The only muscle result comes from mice given CJC-1295 with ipamorelin while losing muscle to steroid drugs. Mouse muscle findings often fail to repeat in humans.
Is CJC-1295 legal to buy or to prescribe in the United States?
No. CJC-1295 has never been approved by the FDA for any use. Pharmacies asked to be allowed to compound it, and FDA flagged it as a possible significant safety risk. That nomination was then withdrawn. Section 503A allows compounding from a bulk substance only if it has a USP-NF monograph, is in an approved drug, or is on FDA's list. FDA's December 2024 briefing says CJC-1295 has no USP monograph and is in no approved drug, and it is not on that list. Anything sold online is unapproved and unregulated. It is also prohibited in competitive sport under anti-doping rules.
Is CJC-1295 the same thing as growth hormone?
No, and the difference is the whole point. Injected growth hormone floods your body from outside. CJC-1295 asks your own pituitary gland to release more of its own. In the trials the natural rhythm survived. Pulses kept their normal timing and size, while the low points between pulses rose sharply. That may be gentler than injecting growth hormone directly. It also means nothing happens if your pituitary cannot respond.
What are the known risks of CJC-1295?
The short trials reported no serious adverse reactions, but they were small and brief. FDA says it has identified serious adverse events linked to CJC-1295. Those include a faster heart rate and a systemic vasodilatory reaction, meaning blood vessels widening across the body. Reviews of growth hormone peptides describe fluid retention, joint and muscle pain, injection site reactions and blood sugar swings. Long term risk, including any cancer risk from raised IGF-1, is unstudied.
Will CJC-1295 show up on a drug test?
Yes, if the test is looking for it. Growth hormone releasing hormones are prohibited under World Anti-Doping Agency rules. Anti-doping labs have built and validated methods that find CJC-1295 and its relatives in urine and blood at picogram levels. The DAC form is harder to catch because it hides on albumin, so labs capture it with antibodies first. If you compete in tested sport, assume it is detectable.

References

  1. 01Teichman SL, et al. (2006). Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. The Journal of clinical endocrinology and metabolism. PMID: 16352683. DOI: 10.1210/jc.2005-1536.
  2. 02Ionescu M, Frohman LA (2006). Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. The Journal of clinical endocrinology and metabolism. PMID: 17018654. DOI: 10.1210/jc.2006-1702.
  3. 03Jette L, et al. (2005). Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. PMID: 15817669. DOI: 10.1210/en.2004-1286.
  4. 04Mayfield CK, et al. (2026). Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians. The American journal of sports medicine. PMID: 41476424. DOI: 10.1177/03635465251357593.
  5. 05Dominikowski A, et al. (2026). The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Frontiers in endocrinology. PMID: 42395176. DOI: 10.3389/fendo.2026.1822475.
  6. 06Gajda PM, et al. (2019). Glycine-modified growth hormone secretagogues identified in seized doping material. Drug testing and analysis. PMID: 30136411. DOI: 10.1002/dta.2489.
  7. 07Coutinho LFD, et al. (2026). A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. The Journal of sports medicine and physical fitness. PMID: 41880199. DOI: 10.23736/S0022-4707.26.17773-1.
  8. 08Knoop A, et al. (2016). Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. Analytical and bioanalytical chemistry. PMID: 26879649. DOI: 10.1007/s00216-016-9377-3.
Chris Hallewell, founder of Underground Biohacking

By , Founder, Underground Biohacking

Last reviewed

The numbers here describe your own vial. They are not medical advice and not a dose suggestion. Confirm your protocol with a qualified clinician.

The full CJC-1295 pageRunning a full cycle?
Worth a look
Sourcing

Recommended Sources

The sources we've assessed against published testing criteria.

View
Coming Soon

The UB App

Run the plan, track it, see what changed.

Join the waitlist